{"id":1715,"date":"2024-05-15T14:35:25","date_gmt":"2024-05-15T21:35:25","guid":{"rendered":"https:\/\/jointechlabs.com\/?post_type=industry-research&p=1715"},"modified":"2024-05-15T14:35:25","modified_gmt":"2024-05-15T21:35:25","slug":"three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease","status":"publish","type":"industry-research","link":"https:\/\/jointechlabs.com\/fr\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/","title":{"rendered":"R\u00e9sultats \u00e0 trois ans de l'injection locale de cellules autologues de fraction vasculaire stromale et de micrograisse dans les fistules p\u00e9rianales r\u00e9fractaires de la maladie de Crohn"},"content":{"rendered":"

Dans une \u00e9tude pilote, incluant des patients souffrant de fistules p\u00e9rianales complexes r\u00e9fractaires, la fraction vasculaire stromale autologue d\u00e9riv\u00e9e de l'adipeuse (ADSVF) combin\u00e9e \u00e0 la micrograisse a permis d'obtenir une r\u00e9mission combin\u00e9e dans 60% des cas, avec un bon profil de s\u00e9curit\u00e9 \u00e0 1 an. L'objectif de cette \u00e9tude est d'\u00e9valuer si ces r\u00e9sultats se maintiennent \u00e0 plus long terme.<\/p>","protected":false},"featured_media":0,"template":"","class_list":["post-1715","industry-research","type-industry-research","status-publish","hentry"],"acf":[],"yoast_head":"\nThree-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease - Jointechlabs, Inc<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jointechlabs.com\/fr\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease\" \/>\n<meta property=\"og:description\" content=\"In a pilot study, including patients with refractory complex perianal fistulas, autologous adipose-derived stromal vascular fraction (ADSVF) combined with microfat achieved combined remission in 60% of cases, with a good safety profile at 1 year. The purpose of this study is to assess whether these results were maintained at longer term.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jointechlabs.com\/fr\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Jointechlabs, Inc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/industry-research\\\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\\\/\",\"url\":\"https:\\\/\\\/jointechlabs.com\\\/industry-research\\\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\\\/\",\"name\":\"Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease - Jointechlabs, Inc\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/#website\"},\"datePublished\":\"2024-05-15T21:35:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/industry-research\\\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jointechlabs.com\\\/industry-research\\\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/industry-research\\\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/jointechlabs.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industry Research\",\"item\":\"https:\\\/\\\/jointechlabs.com\\\/industry-research\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/#website\",\"url\":\"https:\\\/\\\/jointechlabs.com\\\/\",\"name\":\"Jointechlabs, Inc\",\"description\":\"Brilliant technology for Microfat\",\"publisher\":{\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jointechlabs.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/#organization\",\"name\":\"Jointechlabs, Inc\",\"url\":\"https:\\\/\\\/jointechlabs.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/jointechlabs.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/jointechlabs-logo-tm.png\",\"contentUrl\":\"https:\\\/\\\/jointechlabs.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/jointechlabs-logo-tm.png\",\"width\":250,\"height\":36,\"caption\":\"Jointechlabs, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/jointechlabs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"R\u00e9sultats \u00e0 trois ans de l'injection locale de cellules autologues de fraction vasculaire stromale et de micrograisse dans les fistules p\u00e9rianales r\u00e9fractaires de la maladie de Crohn - Jointechlabs, Inc","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jointechlabs.com\/fr\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/","og_locale":"fr_FR","og_type":"article","og_title":"Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease","og_description":"In a pilot study, including patients with refractory complex perianal fistulas, autologous adipose-derived stromal vascular fraction (ADSVF) combined with microfat achieved combined remission in 60% of cases, with a good safety profile at 1 year. The purpose of this study is to assess whether these results were maintained at longer term.","og_url":"https:\/\/jointechlabs.com\/fr\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/","og_site_name":"Jointechlabs, Inc","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/jointechlabs.com\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/","url":"https:\/\/jointechlabs.com\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/","name":"R\u00e9sultats \u00e0 trois ans de l'injection locale de cellules autologues de fraction vasculaire stromale et de micrograisse dans les fistules p\u00e9rianales r\u00e9fractaires de la maladie de Crohn - Jointechlabs, Inc","isPartOf":{"@id":"https:\/\/jointechlabs.com\/#website"},"datePublished":"2024-05-15T21:35:25+00:00","breadcrumb":{"@id":"https:\/\/jointechlabs.com\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jointechlabs.com\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/jointechlabs.com\/industry-research\/three-year-outcome-of-local-injection-of-autologous-stromal-vascular-fraction-cells-and-microfat-in-refractory-perianal-fistulas-of-crohns-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jointechlabs.com\/"},{"@type":"ListItem","position":2,"name":"Industry Research","item":"https:\/\/jointechlabs.com\/industry-research\/"},{"@type":"ListItem","position":3,"name":"Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease"}]},{"@type":"WebSite","@id":"https:\/\/jointechlabs.com\/#website","url":"https:\/\/jointechlabs.com\/","name":"Jointechlabs, Inc","description":"Une technologie brillante pour Microfat","publisher":{"@id":"https:\/\/jointechlabs.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jointechlabs.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/jointechlabs.com\/#organization","name":"Jointechlabs, Inc","url":"https:\/\/jointechlabs.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/jointechlabs.com\/#\/schema\/logo\/image\/","url":"https:\/\/jointechlabs.com\/wp-content\/uploads\/2022\/07\/jointechlabs-logo-tm.png","contentUrl":"https:\/\/jointechlabs.com\/wp-content\/uploads\/2022\/07\/jointechlabs-logo-tm.png","width":250,"height":36,"caption":"Jointechlabs, Inc"},"image":{"@id":"https:\/\/jointechlabs.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/jointechlabs.com\/fr\/wp-json\/wp\/v2\/industry-research\/1715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jointechlabs.com\/fr\/wp-json\/wp\/v2\/industry-research"}],"about":[{"href":"https:\/\/jointechlabs.com\/fr\/wp-json\/wp\/v2\/types\/industry-research"}],"wp:attachment":[{"href":"https:\/\/jointechlabs.com\/fr\/wp-json\/wp\/v2\/media?parent=1715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}